Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 1.1 Exhibit 1.1 Underwriting Agreement, Dated May 27, 2021, by and Between the Company and Maxim Group LLC, As Representative of the Underwriters
- 3.1 Exhibit 3.1 Certificate of Amendment Filed with the Secretary of State of the State of Nevada
- 4.1 Exhibit 4.1 Form of REPRESENTATIVE’S Warrant
- 4.2 Exhibit 4.2 Form of Common Stock Warrant
- 4.3 Exhibit 4.3 Warrant Agency Agreement, Dated June 2, 2021, by and Between the Company and Direct Transfer LLC
- 99.1 Exhibit 99.1 Press Release of the Company, Dated May 27, 2021
- 99.2 Exhibit 99.2 Press Release of the Company, Dated June 2, 2021
ZIVO similar filings
- 12 Oct 21 Regulation FD Disclosure
- 21 Sep 21 Departure of Directors or Certain Officers
- 16 Sep 21 Submission of Matters to a Vote of Security Holders
- 2 Jun 21 Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
- 17 Mar 21 Regulation FD Disclosure
- 12 Feb 21 Departure of Directors or Certain Officers
- 7 Jan 21 Zivo Bioscience Names Keith R. Marchiando As Chief Financial Officer
Filing view
External links
